✦ LIBER ✦

Drug-Eluting Stents: Life Insurance With a Better Death Benefit

✍ Scribed by H. Vernon Anderson

Book ID: 119267433
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 71 KB
Volume: 51
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2008.02.053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of a Novel Drug-Elut

Safety and Efficacy of a Novel Drug-Eluting Stent With a Bioresorbable Polymer in a Real Life Cohort

✍ Guilbert-Vandal, G.; ElKhoury, R.; Bertrand, M.; Kouz, R.; Stevens, L.; Noiseux, 📂 Article 📅 2013 🏛 Pulsus Group Inc 🌐 English ⚖ 341 KB

TCT-408: Clinical Outcome in Patients Tr

TCT-408: Clinical Outcome in Patients Treated with a New Generation Drug Eluting Stents in a Real Life Setting

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Gender-related differences of diabetic p

✍ Buja, Paolo; D'Amico, Gianpiero; Facchin, Michela; Barioli, Alberto; Napodano, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 427 KB

Benefit of Long-Term Dual Anti-Platelet

Benefit of Long-Term Dual Anti-Platelet Therapy in Patients Treated With Drug-Eluting Stents: From the NHLBI Dynamic Registry

✍ Mulukutla, Suresh R.; Marroquin, Oscar C.; Vlachos, Helen A.; Selzer, Faith; Tom 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 360 KB

TCT-199 Safety and efficacy of a novel d

TCT-199 Safety and efficacy of a novel drug-eluting stent with a bioresorbable polymer in a real life cohort

✍ Mansour, Samer; Guilbert-Vandal, Gabrielle; Bertrand, Marie-Jeanne; Kouz, Remi; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Lack of clinical long-term benefit with

Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts

✍ Giuseppe Gioia; Alberto Benassi; Raghar Mohendra; Khaza Chowdhury; Iqbal Masood; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 3 views

## Abstract Background: Small randomized trials have shown short‐term improved outcome with drug‐eluting stents (DES) over bare metal stent (BMS) in saphenous vein graft (SVG) interventions by reducing in‐stent restenosis and target vessel revascularization (TVR). It is not clear, however, if these